dentalcorp (TSE:DNTL – Get Free Report) had its price objective upped by analysts at Desjardins from C$10.50 to C$11.00 in a research report issued on Monday, BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Desjardins’ target price suggests a potential upside of 37.50% from the stock’s current price.
A number of other equities research analysts have also recently issued reports on DNTL. Canaccord Genuity Group decreased their target price on dentalcorp from C$10.50 to C$10.25 and set a “buy” rating for the company in a research report on Monday, May 13th. BMO Capital Markets lowered their price target on shares of dentalcorp from C$11.00 to C$10.00 and set an “outperform” rating on the stock in a report on Monday, May 13th. One research analyst has rated the stock with a sell rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of C$10.08.
Get Our Latest Stock Report on dentalcorp
dentalcorp Stock Down 0.7 %
dentalcorp Company Profile
dentalcorp Holdings Ltd., through its subsidiaries, engages in the acquiring and partnering with dental practices to provide health care services in Canada. The company was formerly known as Dentalcorp Overbite Ltd. dentalcorp Holdings Ltd. was founded in 2011 and is headquartered in Toronto, Canada.
Recommended Stories
- Five stocks we like better than dentalcorp
- How to Use the MarketBeat Stock Screener
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- What Investors Need to Know About Upcoming IPOs
- Leading Gold Stock Shines With Q2 2024 Earnings Release
- Financial Services Stocks Investing
- Pharma Giant’s Shares Up After Impressive Q2 Earnings Release
Receive News & Ratings for dentalcorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for dentalcorp and related companies with MarketBeat.com's FREE daily email newsletter.